NCT05212311

Brief Summary

\- This study will be conducted to answer the following question: Is there a statistically significant effect of chitosan phonophoresis on ulnar nerve conduction velocity, pain level \& function in patients with mild to moderate cubital tunnel syndrome? \- Fifty-four subjects suffering from mild to moderate cubital tunnel syndrome according to modified McGowan grading system (Palmer \& Hughes, 2010) from both sexes diagnosed clinically by electromyography will be recruited for this study. The Age of the participants will range from 20 - 40 years old. Participants with Body mass index between 18.5 and 24.9kg/m2. EMS physio Ltd ultrasound device will be used in combination with chitosan nanoparticles gel. Electrodiagnostic test will be performed for ulnar nerve conduction velocity using Neuropack S1 MEB-9004 NIHON KODEN, JAPAN. Visual analogue scale (VAS) will be used to determine pain level. Quick DASH will be used to determine hand function.Patients will have 3 sessions per week for 5 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 15, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 28, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

March 8, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

June 18, 2023

Status Verified

June 1, 2023

Enrollment Period

1.1 years

First QC Date

January 15, 2022

Last Update Submit

June 14, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in ulnar nerve conduction velocity from baseline and 5 weeks posttreatment

    Measurement of how quickly an electrical impulse moves along the nerve.

    Changes in ulnar nerve conduction velocity from baseline and 5 weeks posttreatment

Secondary Outcomes (2)

  • Changes in pain intensity at 5 weeks posttreatment

    Changes in pain intensity from baseline and 5 weeks posttreatment

  • Changes in function using QUICK DASH scale at 5 weeks posttreatment

    Changes in function using QUICK DASH scale from baseline and 5 weeks posttreatment

Study Arms (2)

Group A (Control group)

ACTIVE COMPARATOR

Group A (n=27) will receive a conventional physical therapy program only for 5 weeks in the form of Splinting, Ultrasound and Exercises.

Device: Chitosan PhonophoresisDevice: SplintingOther: Neural mobilization exercises of the ulnar nerve

Group B (Chitosan phonophoresis group)

EXPERIMENTAL

Patients in group B (n=27) will receive phonophoresis with chitosan nanoparticles. Patients will also receive the conventional physical therapy program: in the form of Splinting, Ultrasound and Exercises. Session will be applied 3 times per week for a total of 5 weeks.

Device: Therapeutic UltrasoundDevice: SplintingOther: Neural mobilization exercises of the ulnar nerve

Interventions

Therapeutic pulsed ultrasound using EMS physio Ltd ultrasound device in presence of chitosan gel will be applied over the elbow. The following parameters will be used: US treatment was applied for 5 min per session at a frequency of 3 MHz and an intensity of 0.5 W/cm2 in pulsed mode with a transducer area of 5 cm2.

Group A (Control group)

US treatment will be applied for 5 min per session at a frequency of 3 MHz and an intensity of 0.5 W/cm2 in pulsed mode with a transducer area of 5 cm2 using aquasonic gel.

Group B (Chitosan phonophoresis group)
SplintingDEVICE

Splinting the elbow in comfortable flexion (40-70), forearm and wrist in neutral (slight forearm pronation and wrist flexion if symptoms are severe), can allow the nerve and surrounding supporting structures the rest and relief from compression and traction. The elbow portion of the splint should be well padded or ''bubbled out'' to provide pressure relief for the area of the cubital tunnel. It may be necessary to splint the ulnar digits of the hand to prevent contracture, maintain passive and active range of motion, and improve hand function. If the motor branch of the nerve is sufficiently involved to cause muscle denervation, a hand-based intrinsic plus splint or the use of finger-based splints to prevent clawing of the ring and small fingers will provide balanced positioning of the affected structures.

Group A (Control group)Group B (Chitosan phonophoresis group)

Nerve mobilization exercises Inflammation or adhesions anywhere along the ulnar nerve path can cause the nerve to have limited mobility and essentially get stuck in one place. These exercises help stretch the ulnar nerve and encourage movement through the cubital tunnel

Group A (Control group)Group B (Chitosan phonophoresis group)

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Fifty-four patients suffering from mild to moderate Cubital tunnel syndrome from both sexes according to modified McGowan grading system (Palmer \& Hughes, 2010) \& have motor conduction velocity across the elbow less than 50 m/s or the difference between the motor conduction velocity across the elbow and that below the elbow exceeds 10 m/s (Padua et al., 2001).
  • Age ranging from 20-35.
  • All participants will have Body mass index between 18.5 and 24.9 kg/m2.

You may not qualify if:

  • Diabetic patients. 2- Cardiovascular patients 3- Patients with cervical spondylosis 4- Patients with cervical disc prolapsed 5- Patients with Thoracic outlet syndrome 6- Patients with carpal tunnel syndrome. 7- Pregnant women 8- Patients with fibromyalgia 9- Patients with epicondylitis 10- Patient with previous elbow injuries 11- Patient with Breast Cancer. 12- Patient with Guyon Canal syndrome 13- Smokers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

October 6 University Hospital

Al Ḩayy Ath Thāmin, Giza Governorate, 12611, Egypt

Location

MeSH Terms

Conditions

Cubital Tunnel SyndromeUlnar Nerve Compression Syndromes

Interventions

Ultrasonic TherapySplints

Condition Hierarchy (Ancestors)

Ulnar NeuropathiesMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Intervention Hierarchy (Ancestors)

DiathermyHyperthermia, InducedTherapeuticsExternal FixatorsOrthopedic Fixation DevicesOrthopedic EquipmentSurgical EquipmentEquipment and SuppliesSurgical Fixation Devices

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 15, 2022

First Posted

January 28, 2022

Study Start

March 8, 2022

Primary Completion

April 1, 2023

Study Completion

April 1, 2023

Last Updated

June 18, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will share

all of the individual participant data collected during the trial and after deidentification

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
6 Months after study publication
Access Criteria
Email: mohamed.magdy.pt@o6u.edu.eg

Locations